How to Treat Sagging Skin

Primary Cause of Sagging: Age-related skin sagging and loss of facial volume are driven by dermal collagen depletion (specifically Type III collagen loss up to 55.9%), matrix breakdown via MMP enzymes, and structural weakening at the dermal-epidermal junction (DEJ).

Hydration vs. Structural Care: Basic hydration only addresses transient surface dryness, whereas targeted biomaterial care restores visible firmness, elasticity, and facial volume fullness.

Dual-Collagen Biomaterial:ProtYouth Dual Recombinant Humanized Collagen Serum combines Recombinant Type III and Type XVII Collagens (4 mg pure active collagen).

Clinical Efficacy (28 Days): Proven to increase overall skin elasticity by 12.76%, visible cheek volume (apple zone fullness) by 8.65%, and reduce marionette line length by 14.02% in human clinical testing.

Loss of skin firmness is rarely an abrupt event. It typically begins with subtle structural shifts: cheeks lose their youthful plumpness, the jawline softens, and marionette lines around the mouth become increasingly visible.

That is why mature skincare requires moving beyond basic surface hydration. Understanding collagen depletion, declining elasticity, and changes in the skin's structural support network is key to addressing skin sagging.

This progressive loss of firmness is driven by changes in the dermal extracellular matrix (ECM). In a preclinical photoaging study published in Bioactive Materials, researchers observed that UV-induced skin damage led to a 55.9% drop in Type III collagen alongside elevated MMP-3 activity (an enzyme responsible for collagen degradation). When treated with recombinant humanized Type III collagen (rhCol III), skin elasticity parameters improved by 11.6% within 5 weeks.

Further research in the Journal of Leather Science and Engineering demonstrated that rhCol III significantly stimulated human dermal fibroblasts, which increases cell migration to 97% (vs. ~63% control) and boostsType I collagen secretion by 2.65 times after 3 days.

While preclinical models do not replace human testing, they provide crucial biological evidence: skin sagging is not simple "dehydration," but a shift in collagen synthesis, degradation, and elastic support.

Many anti-aging routines fail because they treat structural sagging with basic moisturizers. The table below outlines why mature skin requires a transition toward targeted collagen biomaterial care:

Mature skin sagging rarely happens in isolation. It presents alongside loss of cheek volume, marionette lines, and periocular wrinkles. Addressing these interconnected concerns requires a multi-collagen framework:

• Type III Collagen: The predominant collagen associated with skin softness, refined texture, and youthful elasticity.
• Type XVII Collagen: A vital transmembrane protein that anchors basal cells and stabilizes the dermal-epidermal junction (DEJ), maintaining inter-layer structural cohesion.

The ProtYouth Single-Ingredient Dual Recombinant Humanized Collagen Serum Ampoule combines Recombinant Type III and Type XVII Collagens, packing 4 mg of pure active dual collagen per sterile dose.

In a 28-day human clinical efficacy trial involving 31 female subjects with mature skin (aged 36–55), the ProtYouth dual-collagen formula demonstrated measurable structural improvements:

• Overall Skin Elasticity: Improved by 12.76%
• Visible Cheek Volume (Apple Zone Fullness): Increased by 8.65%
• Perioral Marionette Line Length: Reduced by 14.02%

In short-term testing, stratum corneum hydration surged by 86.78% within 15 minutes of application, while skin smoothness improved by 10.12% and roughness decreased by 10.46% after 24 hours. This confirms that the formula concurrently combats immediate dryness while systematically supporting long-term firmness and volume fullness.

When skin shows persistent volume loss and softening contours, your daily skincare strategy should evolve beyond basic hydration. Follow these three criteria when selecting your anti-aging care:

1. Verify the Biomaterial Source: Look for Class-A Recombinant Humanized Collagen engineered for 100% human sequence compatibility.
2. Match Collagen Types to Skin Stage: Select specific collagens(e.g., Type III for elasticity, Type XVII for DEJ connection) tailored to your primary skin concerns.
3. Demand Human Efficacy Data: Prioritize formulas supported by measured, peer-reviewed human clinical metrics over subjective marketing claims.

Addressing sagging skin does not require overloading your vanity. By shielding skin from UV damage, supporting dermal collagen architecture, and choosing scientifically validated biomaterials, you can achieve lasting firmness, bounce, and refined facial contours.